rusfertide
protagonist therapeutics
['rusfertide', 'ptg-300']
during #asco22, dr. ronald hoffman will share information on the following study: rusfertide (ptg-300) treatment in phlebotomy-dependent polycythemia vera patients. #oncology 
An international leader in medical and scientific training, biomedical research, and patient care. It is the medical school for @MountSinaiNYC.